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Abstract
A thorough genetic mapping study was performed to identify predisposing genes for alcoholism
dependence using the Collaborative Study on the Genetics of Alcoholism (COGA) data. The
procedure comprised whole-genome linkage and confirmation analyses, single locus and haplotype
fine mapping analyses, and gene × environment haplotype regression. Stratified analysis was
considered to reduce the ethnic heterogeneity and simultaneously family-based and case-control
study designs were applied to detect potential genetic signals. By using different methods and
markers, we found high linkage signals at D1S225 (253.7 cM), D1S547 (279.2 cM), D2S1356 (64.6
cM), and D7S2846 (56.8 cM) with nonparametric linkage scores of 3.92, 4.10, 4.44, and 3.55,
respectively. We also conducted haplotype and odds ratio analyses, where the response was the
dichotomous status of alcohol dependence, explanatory variables were the inferred individual
haplotypes and the three statistically significant covariates were age, gender, and max drink (the
maximum number of drinks consumed in a 24-hr period). The final model identified important AD-
related haplotypes within a candidate region of NRXN1 at 2p21 and a few others in the inter-gene
regions. The relative magnitude of risks to the identified risky/protective haplotypes was elucidated.
Background
Alcohol dependence (AD) is a complex disorder accompa-
nying familial aggregation and etiological heterogeneity.
The development of AD involves genetic and environ-
mental components as well as gene × gene and gene ×
environmental interactions. Due to these factors, results
from different studies often diverge [1].
Owing to the advancement of biotechnology, enormous
numbers of short tandem repeat polymorphisms (STRPs)
and single-nucleotide polymorphisms are available to
help the process of gene mapping. In this report, STRP and
SNP markers were integrated and a five-stage procedure
was designed to identify the putative AD loci and to eluci-
date the genotype-phenotype-covariate relationship. Dif-
ferent methodologies (linkage analysis, association fine
mapping, haplotype inference, and regression model)
were considered for statistical analyses, different popula-
tions (whole, non-Black, and non-White populations) for
heterogeneity issues, different types of markers (STRPs
and SNPs) for linkage mapping, different densities of
SNPs (Illumina and Affymetrix) for association study, and
different data structures (family data and case-control
data) for study design to yield reliable conclusions.
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Methods
Data description
From the COGA ascertainment criteria, the numbers of
total patients, pure unaffected individuals, and others
were 643 (39.84%), 285 (17.66%), and 686 (42.50%),
respectively. The category "others" was considered as
"unknown" throughout our analyses. On average, 60% of
parents' genotypes were available.
In total, 315 STRPs, 4,720 Illumina SNPs, and 11,120
Affymetrix SNPs on the 22 autosomal chromosomes with
average spacing of 11.53 cM, 0.75 cM, and 0.32 cM were
considered. The genetic map was provided by the Genetic
Analysis Workshop 14 (GAW14) working group.
Ethnic heterogeneity was considered by stratifying the
studied families as pure "non-Black" and "non-White"
families, i.e., families where none of the members were
from the Black population and vice versa. The non-Black
population contained 1,300 individuals from 119 fami-
lies and non-White families contained 247 individuals
from 19 families. Other families were not included in this
report. In addition to family data, founders from each
family were selected for case-control data that contained
The flow chart of statistical analyses Figure 1
The flow chart of statistical analyses.BMC Genetics 2005, 6:S30
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505 individuals with 52 affected (cases), 127 unaffected
(controls) and 326 individuals with other phenotypes.
Statistical methods
To explore the phenotype × genotype relationship and
locate the AD predisposing genes, we carried out a five-
stage procedure. The first stage was designed to search the
potential candidate regions by considering a genome-
wide linkage analysis using the STRP markers. GENE-
HUNTER [2] and SIMWALK2 [3] were employed to con-
duct multipoint nonparametric linkage (NPL) analysis,
using the 'all' scoring function. Five evenly spaced posi-
tions scanning between markers were used. The allele fre-
quencies were provided by GAW14 working group. A
chromosome region with an NPL score greater than 3 was
identified as "highly linked with AD".
The second stage used denser SNP markers to confirm
linkage results obtained in the first stage. On the basis of
the NPL scores from the first stage, a candidate region was
defined to be a segment in which all NPL scores exceeded
1 and the maximal NPL score exceeded 3. In the candidate
regions, SIMWALK2 [3] was carried out for multipoint
linkage analyses using Illumina and Affymetrix SNP mark-
ers. The results were compared with those obtained from
the first stage.
In the third stage, association analyses were conducted
using SNPs to further narrow the candidate region. Trans-
mission disequilibrium tests were performed by using
PDT [4] and FBAT [5] for family data, and linkage disequi-
librium tests (allele-based association test [6]) were used
for case-control data.
NPL scores of genome-wide linkage analysis Figure 2
NPL scores of genome-wide linkage analysis.
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Table 1: Summary of results of transmission and linkage disequilibrium tests
Chr. SNP Position PDT FBAT Allele
1 rs1906255 182.8 2.75
tsc0073840 204.8 2.02
tsc0982091 212.1 2.41
tsc1100744 213.3 2.49
rs908857 214.1 2.37
tsc0054439 215.3 2.13
tsc1512021 219.3 2.29
tsc0040851 219.6 2.42
tsc0056649 224.8 2.60
tsc0576563 225.6 2.25
tsc1001020 226.4 3.42
tsc0059489 226.7 2.88
tsc0990050 229.3 4.22
tsc0998408 234.7 2.01
tsc0272628 238.9 2.68
tsc0832886 248.6 2.99
rs946001 257.0 2.41
tsc0046578 260.0 2.99
2 tsc1457260 40.79 2.04
tsc0275086 45.06 2.49
rs2033654 47.60 2.30 2.09
tsc1518799 55.32 2.69
rs927087 56.10 2.25
tsc0273405 56.65 2.81
tsc0764714 59.83 2.00
rs726548 66.90 2.00
tsc0788448 71.22 2.15
tsc0043992 75.99 3.15
tsc0270239 80.94 2.17
rs2008312 88.20 2.46
rs977744 102.1 3.93
tsc0794923 102.5 2.13
7 tsc0050391 5.21 2.02
tsc1110728 13.65 2.02
tsc0847689 17.81 2.88
tsc0064419 18.04 2.60
tsc0247731 20.41 2.38
tsc1061178 29.05 2.08
rs957960 29.30 2.02
tsc0331830 33.94 2.15
tsc0050450 35.30 2.07
rs798646 37.90 2.14
tsc0593964 42.62 2.72 3.48
tsc0042959 44.49 2.69
tsc0051325 47.56 2.17 2.24
tsc0054307 47.85 2.17 2.24
tsc0462262 61.4514 2.45
tsc1241245 62.6748 2.14
tsc0893346 63.6850 2.37
tsc0065973 70.5578 2.00
tsc0260324 73.8253 2.13
tsc0525473 75.0415 2.26
tsc1407569 75.6400 4.75BMC Genetics 2005, 6:S30
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In the fourth stage, anchor markers were selected on the
basis of results from the third stage. HAPLOVIEW [7] was
used to construct haplotype blocks and select tag SNPs in
the region determined by anchors and nearby markers.
Inferences on genotype-phenotype relationship were
drawn by results obtaining from haplotype analysis using
SIMWALK2 [3] for family data and PHASE2 [8] for case-
control data.
In the fifth stage, the relationships between genotype,
phenotype, and covariates underlying the complex alco-
holism etiology was further explored. The individual hap-
lotypes were inferred based on results obtained from
SIMWALK2 [3] for family data and PHASE2 [8] for case-
control data. The inferred individual haplotypes and
important demographic variables, risk factors, and other
phenotypes were modelled simultaneously with the
explanatory variables in the regression models. For fam-
ily-based analysis, the generalized estimating equation
approach using the procedure GENMOD of the package
SAS/STAT [9] was applied; for case control analysis, an
unconditional logistic regression using the procedure
LOGISTIC of the package SAS/STAT [9] was applied. The
flow chart of statistical analyses is shown in Figure 1.
Results
A genome-wide multipoint linkage analysis for the 22
pairs of autosomal chromosomes based on the 315-STRP
markers using GENEHUNTER [2] was conducted. Figure 2
(the green solid line) shows that NPL score > 3 only occurs
on chromosome 7 and the highest NPL score (3.54866) is
located at D7S2846.
To reduce false-positives due to population heterogeneity,
stratified analyses by selecting non-Black and non-White
subpopulations from the whole population was con-
ducted. Whole-genome linkage mapping with STRP mark-
ers was applied to these two subpopulations and yielded
rather different results compared with the whole popula-
tion. The results are shown in Figure 2. For the non-White
population (the blue dashed line), no NPL score was
found to be larger than 3, which might be due to small
sample size in this subpopulation. For the non-Black pop-
ulation (the orange dot-point line), the NPL scores for
D1S225, D1S547, and D2S1356 are 3.91886, 4.10389,
and 4.43759, respectively. Results obtained from GENE-
HUNTER [2] and SIMWALK2 [3] are quite consistent
(results not shown).
In the second stage, we conducted SNPs linkage analysis
to confirm the STRP linkage results of chromosomes 1, 2,
and 7 found in the first stage. The three candidate regions
determined by the mentioned criteria were D1S518-
D1S547, D2S320-D2S436, and D7S1790-D7S665. In
these three candidate regions, the Linkage III Panel of
SNPs of Illumina consists of 38, 151, and 103 SNPs and
the inter-marker distances are 0.99, 0.53, and 0.74 cM in
average. The GeneChip Mapping 10 K Array marker set of
SNPs of Affymetrix consists of 113, 344, and 238 SNPs
and the average distances between markers are 0.47, 0.23,
and 0.30 cM. The results confirm the previous linkage
results and find significant Illumina and Affymetrix SNPs
with NPL scores > 3 on chromosome 2 as shown in Figure
1; however, the NPL curves are not the same as the curve
obtained from STRPs previously.
In the third stage, further fine mapping was pursued to
narrow down the candidate regions using association
tests. Based on family-based transmission disequilibrium
tests (PDT [4] and FBAT [5]) and case-control linkage dis-
equilibrium tests (allele-based test [6]), the SNPs associ-
ated with AD (p-value < 0.01) without correcting multiple
tests are shown in Table 1, where p-values are transformed
by taking -log10.
In the fourth stage, we selected the most significant SNPs
to be anchor markers based on Table 1 and preceded with
finding haplotype blocks and tag SNPs in the region. Only
the block closest to the anchor marker was used to con-
duct haplotype analysis without adjusting covariates.
However, no significant haplotypes were found.
In the fifth stage, haplotype regression analyses consider-
ing three significant covariates (age, gender, and max
Table 2: Summary of results of haplotype analysis with covariates
Study design Chr SNPs in haplotype Significant haplotypes OR (95% CI)
Family-based 1 tsc0046578a-tsc0938317 ---b ---
Family-based 2 tsc0063067-tsc0059588-tsc0043992-tsc1473501a 2222 0.65 (0.45, 0.93)
Family-based 7 tsc0018713-tsc0018712-tsc0593964a 111 2.13 (1.09, 4.15)
Case control 1 tsc0949090-tsc0755351-tsc0990050a --- ---
Case control 2 rs977744a-tsc0794923 11 0.001 (<0.001, 0.207)
12 0.009 (0.001, 0.171)
Case control 7 tsc0272090-tsc1407569a --- ---
aAnchor marker
b---, no significant haplotypes were identified.BMC Genetics 2005, 6:S30
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drink) were conducted, which were selected in prelimi-
nary analysis. Results of adjusted odds ratio are summa-
rized in Table 2. On chromosome 1, no significant
haplotypes were found. On chromosome 2, haplotypes
11 and 12 constituted by SNPs rs977744 and tsc0794923
yield ORs 0.001 and 0.009 and 95% CIs (<0.001, 0.207)
and (0.001, 0.171), respectively, and show strong protec-
tive effects; haplotype 2222, comprising SNPs
tsc0063067, tsc0059588, tsc0043992, and tsc1473501 at
gene NRXN1, yields an OR of 0.65 with 95% CI (0.45,
0.93). On chromosome 7, haplotype 111 from SNPs
tsc0018713, tsc0018712, and tsc0593964 is a risk haplo-
type with an OR of 2.13 and corresponding 95% CI (1.09,
4.15).
Discussion
In summary, some potential candidate regions on chro-
mosomes 1, 2, and 7 linked with AD susceptibility loci
were found. These findings are consistent with previous
reports [10,11]. Moreover, association and haplotype
analyses further narrowed the candidate region. On chro-
mosome 2, a haplotype within the intronic region of gene
NRXN1 related to polymorphic cell surface proteins was
identified, as well as two strongly protective haplotypes in
inter-gene regions. On chromosome 7, one moderately
risky haplotype in an inter-gene region was identified.
These results should be useful to biologists for the
advanced study of functional cloning.
The linkage scans based on three different marker sets
were compared. The curves of NPL scores based on two
SNP sets are quite similar; however, the SNP scans and
STRP scan show somewhat inconsistent results on differ-
ent chromosomes. On chromosome 2, SNP linkage scan
confirms STRP scan and yields more and higher linkage
signals in the same region. In other candidate regions,
SNP scans fail to identify any important SNPs, probably
due to their lower information content. We also com-
pared the results from three association tests and found
many different significant SNPs based on family-based
and case control association tests. The differences were
probably due to the different samples used in the analyses
and information extracted from transmission and linkage
disequilibrium tests.
Our five-stage gene mapping procedure is elaborate
though incomplete. Other analytical strategies, such as
quantitative trait analysis, will provide complementary
information to further dissect the etiology of AD.
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